AlloVir Inc. (ALVR) Social Stream
Allovir Inc (ALVR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALVR.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 28 weeks, ALVR's average price target has gone down $11.5.
ALVR reports an average of 171.99% for its upside potential over the past 43 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ALVR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 18 months, ALVR's average broker recommendation rating worsened by 0.25.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALVR as an investment opportunity.
- Allovir Inc's upside potential (average analyst target price relative to current price) is greater than 578.33% of all US stocks.
- ALVR has a higher number of analysts covering the stock than 114.48% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, Allovir Inc's variance in analysts' estimates is lower than -305.89% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Allovir Inc's average analyst price target is greater than 376.76% of them.
Is ALVR a Buy, Hold or Sell? See the POWR Ratings now!